MLchartDataset catalogue

carboplatin-paclitaxel-bevacizumab regimen

Term · Oncology and biomedicine · MLC-T-ONC-001417

A chemotherapy combination used to treat advanced, nonsquamous non-small cell lung cancer. It includes the drugs carboplatin, paclitaxel (Taxol), and bevacizumab. Also called carboplatin-Taxol-bevacizumab regimen.

Table 1. Record
IdentifierMLC-T-ONC-001417
FieldOncology and biomedicine
Synonymscarboplatin-Taxol-bevacizumab regimen
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-001417",
  "term": "carboplatin-paclitaxel-bevacizumab regimen",
  "field": "Oncology and biomedicine",
  "definition": "A chemotherapy combination used to treat advanced, nonsquamous non-small cell lung cancer. It includes the drugs carboplatin, paclitaxel (Taxol), and bevacizumab. Also called carboplatin-Taxol-bevacizumab regimen.",
  "synonyms": [
    "carboplatin-Taxol-bevacizumab regimen"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/carboplatin-paclitaxel-bevacizumab-regimen/"
}

Record 4,205 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.